JBT Marel (JBTM) Q4 FY25 earnings call

JBT Marel completed its first year as a combined entity, demonstrating successful integration with strong revenue growth and significant margin expansion. The company exceeded its deleveraging target and achieved adjusted EPS accretion, driven by robust protein demand and synergy realization. Despite tariff headwinds and some segment-specific challenges, management is optimistic about continued growth and margin progression, with a focus on strategic integration and capital efficiency.